Summary of Study ST000876

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench,, where it has been assigned Project ID PR000607. The data can be accessed directly via it's Project DOI: 10.21228/M86Q34 This work is supported by NIH grant, U2C- DK119886.


Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files
Study IDST000876
Study TitleHuman serum for a patient with neuropathy being treated with L-serine.
Study Typedrug dosage
Study SummaryOral serine dosing over 52 week study period
University of Helsinki
DepartmentMolecular Neurology
Last NameYlikallio
First NameEmil
AddressHartmaninkatu 8, 00290 Helsinki, Finland
Submit Date2017-09-05
PublicationsClinical and metabolic consequences of L-serine supplementation in hereditary sensory and autonomic neuropathy type 1C, Cold Spring Harbor Molecular Case Studies
Analysis Type DetailMS(Dir. Inf.)
Release Date2017-10-11
Release Version1
Emil Ylikallio Emil Ylikallio application/zip

Select appropriate tab below to view additional metadata details:


Treatment ID:TR000917
Treatment Summary:Oral L-serine
Treatment Compound:L-serine
Treatment Route:Oral
Treatment Dose:0-400 mg/kg/day
Treatment Doseduration:52 weeks